Many leading cancer centers have begun to offer molecular testing to guide the use of targeted therapies in
both clinical trials and direct patient care. These pioneering efforts have created a foundation for personalized medicine.
Still, analyzing and interpreting the molecular underpinnings of tumors is often too complex to be part of the current
standard-of-care in the community, and as a result, truly customized cancer care remains out of reach for most patients.
Intervention Insights has picked up the challenge to bring the clear advantages of personalized medicine to the
community setting. We work closely with our clinical oncology and research collaborators to develop and continuously
improve OncInsights, our therapeutic information service, in support of our oncology partners and their
patients’ battle against cancer.